HU6 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02 (month) in 4mo
ESTIMATED |
READOUT
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Place
Phase 2 · MASH - Metabolic Dysfunction-Associated Steatohepatitis |
Rivus Pharmaceuticals, Inc. | HU6 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
|